FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease.

MLA

Neira, Gabriela, et al. “FNDC4 Reduces Hepatocyte Inflammatory Cell Death via AMPKα in Metabolic Dysfunction-Associated Steatotic Liver Disease.” Clinical Nutrition (Edinburgh, Scotland), vol. 43, no. 9, Sept. 2024, pp. 2221–33. EBSCOhost, https://doi.org/10.1016/j.clnu.2024.08.007.

APA

Neira, G., Becerril, S., Valentí, V., Moncada, R., Catalán, V., Gómez-Ambrosi, J., Colina, I., Silva, C., Escalada, J., Frühbeck, G., & Rodríguez, A. (2024). FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease. Clinical Nutrition (Edinburgh, Scotland), 43(9), 2221–2233. https://doi.org/10.1016/j.clnu.2024.08.007

Chicago

Neira, Gabriela, Sara Becerril, Víctor Valentí, Rafael Moncada, Victoria Catalán, Javier Gómez-Ambrosi, Inmaculada Colina, et al. 2024. “FNDC4 Reduces Hepatocyte Inflammatory Cell Death via AMPKα in Metabolic Dysfunction-Associated Steatotic Liver Disease.” Clinical Nutrition (Edinburgh, Scotland) 43 (9): 2221–33. doi:10.1016/j.clnu.2024.08.007.